Myrrh mediates haem oxygenase-1 expression to suppress the lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 9, 2011, Pages 1211-1218

  Cheng, Yu Wen ^a   Cheah, Khoot Peng ^d   Lin, Che Wei ^d   Li, Joe Sharg ^d   Yu, Wen Yu ^d   Chang, Ming Long ^d   Yeh, Geng Chang ^b   Chen, Sheng Hsuan ^d,e   Choy, Cheuk Sing ^c,d,f   Hu, Chien Ming ^c,d  

^a Department of Biological Science and Technology   (Taiwan)

^b Fu Jen Catholic Uiversity   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e Mennonite Christian Hospital   (Taiwan)

^f TAIPEI HOSPITAL   (Taiwan)

Author keywords

cyclooxygenase 2; haem oxygenase 1; inducible nitric oxide synthase; lipopolysaccharide; myrrh

Indexed keywords

CYCLOOXYGENASE 2; HEME OXYGENASE 1; HERBACEOUS AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; METHANOL; MYRRH EXTRACT; NITRIC OXIDE; PROSTAGLANDIN E2; PROTOPORPHYRIN ZINC; PROTOPORPHYRIN ZINC IX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; COMMIPHORA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; DRUG DETERMINATION; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVATION; ENZYME SYNTHESIS; MACROPHAGE; MYRRH; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COMMIPHORA; HEME OXYGENASE-1; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 80051685813     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01329.x     Document Type: Article

References (48)

1. El Ashry ES, et al,. Components, therapeutic value and uses of myrrh. Pharmazie 2003; 58: 163-168. (Pubitemid 36373070)
2. Shen T, et al,. Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in Chinese traditional medicine. Chem Biodivers 2008; 5: 540-553.
3. Deng R,. Therapeutic effects of guggul and its constituent guggulsterone: Cardiovascular benefits. Cardiovasc Drug Rev 2007; 25: 375-390. (Pubitemid 350233357)
4. Ashry KM, et al,. Oxidative stress and immunotoxic effects of lead and their amelioration with myrrh (Commiphora molmol) emulsion. Food Chem Toxicol 2010; 48: 236-241.
5. Briekskorn CH, et al,. Constituents of essential oil of myrrh II: sesquiterpenes and furanosesquiterpenes. Planta Med 1982; 44: 87-90.
6. Zhu N, et al,. Isolation and characterization of several aromatic sesquiterpenes from Commiphora myrrha. Flavour Fragr J 2003; 18: 282-285. (Pubitemid 36949984)
7. Dolara P, et al,. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med 2000; 66: 356-358. (Pubitemid 30346301)
8. Haffor A-SA,. Effect of myrrh (Commiphora molmol) on leukocyte levels before and during healing from gastric ulcer or skin injury. J Immunotoxicol 2010; 7: 68-75.
9. 4-induced oxidative damage in rats. Food Chem Toxicol 2008; 46: 3182-3185.
10. Tipton DA, et al,. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro 2003; 17: 301-310. (Pubitemid 36627749)
11. 2 production in human gingival fibroblasts and epithelial cells. Toxicol In Vitro 2006; 20: 248-255. (Pubitemid 43087708)
12. Al-Harbi MM, et al,. Anticarcinogenic effect of Commiphora molmol on solid tumors induced by Ehrlich carcinoma cells in mice. Chemotherapy 1994; 40: 337-347. (Pubitemid 24242723)
13. Nohr LA, et al,. Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. Complement Ther Med 2009; 17: 16-22.
14. Verma SK, et al,. Effect of commiphora mukul (gum guggulu) in patients of hyperlipidemia with special reference to HDL-cholesterol. Ind J Med Res 1988; 87: 356-360.
15. Szapary PO, et al,. Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial. JAMA 2003; 290: 765-772. (Pubitemid 37432953)
16. Urizar NL, et al,. Gugulipid: a natural cholesterol-lowering agent. Annu Rev Nutr 2003; 23: 303-313. (Pubitemid 37059726)
17. Abdul-Ghani AS, et al,. Effect of aqueous extract of Commiphora copobalsamum on blood pressure and heart rate. J Ethnopharmacol 1997; 57: 219-222.
18. Sinal CJ, et al,. Guggulsterone: an old approach to a new problem. Trends Endocrinol Metab 2002; 13: 275-276. (Pubitemid 36733953)
19. Lv N, et al,. Guggulsterone, a plant sterol, inhibits NF-κB activation and protects pancreatic β cells from cytokine toxicity. Mol Cell Endocrinol 2008; 289: 49-59.
20. Gujral ML, et al,. Antiarthritic and anti-inflammatory activity of gum guggul (Balsamodendron mukul Hook). Indian J Physiol Pharmacol 1960; 4: 267-273.
21. Singh BB, et al,. The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study. Altern Ther Health Med 2003; 9: 74-79. (Pubitemid 36576283)
22. Meselhy MR,. Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents. Phytochemistry 2003; 62: 213-218. (Pubitemid 36857591)
23. Shishodia S, et al,. Guggulsterone inhibits NF-κB and IκBα kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem 2004; 279: 47148-47158. (Pubitemid 39518371)
24. Darshan S, et al,. Patented antiinflammatory plant drug development from traditional medicine. Phytother Res 2004; 18: 343-357. (Pubitemid 38765121)
25. Matsuda H, et al,. Absolute stereostructures of polypodane- and octanordammarane-type triterpenes with nitric oxide production inhibitory activity from guggul-gum resins. Bioorg Med Chem 2004; 12: 3037-3046. (Pubitemid 38622137)
26. Blantz RC, et al,. Role of nitric oxide in inflammatory conditions. Nephron 2002; 90: 373-378. (Pubitemid 34310099)
27. Harris SG, et al,. Prostaglandins as modulators of immunity. Trends Immunol 2002; 23: 144-150. (Pubitemid 34178297)
28. Morse D, et al,. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 2003; 278: 36993-36998. (Pubitemid 37175212)
29. Nomura Y,. NF-κB activation and IκB-a dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci 2001; 68: 1695-1701. (Pubitemid 32245618)
30. Otterbein LE, et al,. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003; 24: 449-455. (Pubitemid 36928103)
31. Surh YJ, et al,. Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res 2009; 32: 1163-1176.
32. Gozzelino R, et al,. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010; 50: 323-354.
33. Wang WW, et al,. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 2004; 40: 424-433. (Pubitemid 39062860)
34. Hu CM, et al,. Heme oxygenase-1 mediates the inhibitory actions of brazilin in RAW264.7 macrophages stimulated with lipopolysaccharide. J Ethnopharmacol 2009; 121: 79-85.
35. Poss KD, et al,. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 1997; 94: 10925-10930. (Pubitemid 27430837)
36. Yachie A, et al,. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-135. (Pubitemid 29031171)
37. Jeong GS, et al,. Effects of sappanchalcone on the cytoprotection and anti-inflammation via heme oxygenase-1 in human pulp and periodontal ligament cells. Eur J Pharmacol 2010; 644: 230-237.
38. Zuckerbraun HL, et al,. Triclosan: cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci 1998; 106: 628-636. (Pubitemid 128737068)
39. Wang CC, et al,. Protective effect of dried safflower petal aqueous extracts and its main constituent, carthamus yellow, against lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophage. J Sci Food Agric 2011; 91: 218-225.
40. Park JH, et al,. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochem Biophys Res Commun 2006; 351: 146-152. (Pubitemid 44635418)
41. Choy CS, et al,. Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW264.7 cells. J Ethnopharmacol 2008; 115: 455-462.
42. McCann SM, et al,. The nitric oxide theory of aging revisited. Ann N Y Acad Sci 2005; 1057: 64-84. (Pubitemid 43211628)
43. Zhang G, et al,. Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 2000; 6: 453-457. (Pubitemid 32409432)
44. Ghosh S, et al,. Missing pieces in the NF-κB puzzle. Cell 2002; 109: 81-96.
45. Baldwin AS Jr,. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683. (Pubitemid 26130197)
46. Baeuerle PA,. IκB-NF-κB structures: at the interface of inflammation control. Cell 1998; 95: 729-731. (Pubitemid 29014451)
47. Li C, et al,. Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 2007; 9: 2227-2239. (Pubitemid 350059011)
48. Pae HO, et al,. Heme oxygenase-1: its therapeutic roles in inflammatory diseases. Immune Netw 2009; 9: 12-19.